Showing results (51-60 of 136) with videos related to
Sort By:
Pageof 14
The Journal of Antimicrobial Chemotherapy|September 17, 1998
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolonesK S Thomson, C C SandersAntimicrobial Agents and Chemotherapy|May 1, 1999
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic modelP D Lister, C C SandersAmerican Journal of Clinical Pathology|March 11, 1975
Effects of procedural variations on the activity of aminoglycosides in vitroC C Sanders, W E SandersThe Journal of Antimicrobial Chemotherapy|June 5, 2001
Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniaeP D Lister, C C SandersAmerican Journal of Clinical Pathology|April 1, 1980
Antagonism of cefamandole by cefoxitin in routine disk susceptibility testsC C Sanders, W E SandersClinical Drug Investigation|August 14, 2016
Cefepime : The Last Generation or the First Enhanced-Potency Broad Spectrum Cephalosporin?C C Sanders, E S MolandThe Journal of Infectious Diseases|July 27, 2001
Invasion of human fallopian tube epithelium by Escherichia coli expressing combinations of a gonococcal porin, opacity-associated protein, and chimeric lipo-oligosaccharideG L Gorby, A F Ehrhardt, M A Apicella, et al.Antimicrobial Agents and Chemotherapy|February 1, 1991
Altered phenotypes associated with ampD mutations in Enterobacter cloacaeG Korfmann, C C Sanders, E S MolandThe Journal of Antibiotics|April 1, 1978
Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in miceR V Goering, C C Sanders, W SandersAntimicrobial Agents and Chemotherapy|July 1, 1991
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymesS J Cavalieri, C C Sanders, C NewPageof 14